HRT Financial’s Avenue Therapeutics ATXI Stock Holding History
Bought
Maintained
Sold
Other funds holding ATXI
SM
HRT Financial's ATXI Position: Q2 2024 in Review
HRT Financial sold out of Avenue Therapeutics (ATXI) in Q2 2024, closing a stake of 616 shares — an estimated $6K sold.
HRT Financial first reported a position in ATXI in Q2 2021 and held it in 5 quarters. The position peaked at $61K in Q2 2021. 9 funds tracked by Wall St. Rank hold ATXI as of Q2 2024.
- HRT Financial reported no remaining Avenue Therapeutics position as of Q2 2024 after selling out during the quarter.
- HRT Financial sold 616 Avenue Therapeutics shares in Q2 2024, an estimated $6K.
- HRT Financial first reported a position in Avenue Therapeutics in Q2 2021 and held it in 5 quarters.
- HRT Financial's Avenue Therapeutics position peaked at $61K in Q2 2021.
- 9 funds tracked by Wall St. Rank held Avenue Therapeutics as of Q2 2024.
Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.